Koen M. Marien

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology.

The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology.

Journal: Breast cancer research : BCR

Published: July 27, 2025

Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression.

Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non-muscle-invasive Bladder Cancer Progression.

Journal: European urology open science

Published: June 19, 2024

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

Journal: PloS one

Published: June 27, 2021

Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer.

Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate Cancer.

Journal: Cancer immunology research

Published: July 24, 2019

The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History.

The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History.

Journal: Pathology oncology research : POR

Published: February 28, 2019

Consensus guidelines for the use and interpretation of angiogenesis assays.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Journal: Angiogenesis

Published: May 17, 2018

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

Journal: Journal of the National Cancer Institute

Published: November 14, 2016

Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.

Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue.

Journal: PloS one

Published: April 28, 2016

AutoTag and AutoSnap: Standardized, semi-automatic capture of regions of interest from whole slide images.

AutoTag and AutoSnap: Standardized, semi-automatic capture of regions of interest from whole slide images.

Journal: MethodsX

Published: January 29, 2015

Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.

Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.

Journal: Expert review of molecular diagnostics

Published: January 15, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026